The Korean Pharmaceutical Association said Friday that nationwide shortages of prefilled insulin pens have eased after domestic fill-finish plants increased shifts, though community pharmacists still report spot shortages of pediatric doses popular with newly diagnosed children.
Supply picture
Association data from 1,200 surveyed pharmacies show in-stock rates for adult rapid-acting pens rose to 92 percent this week from 78 percent in late September, when import delays coincided with a flu vaccination rush that crowded cold-chain logistics.
Domestic contract manufacturers hired temporary technicians to run additional overnight lines sterilizing glass cartridges. The Ministry of Food and Drug Safety expedited batch release for two locally labeled products without waiving stability testing.
Remaining gaps
Pediatric endocrinologists said 0.5-unit increment pens remain harder to find outside Seoul, forcing some families to use vial-and-syringe regimens that raise dosing error risk. The association asked insurers to temporarily reimburse pharmacists for compounding services when pens are unavailable.
Patient guidance
Officials urged patients not to hoard pens as stocks normalize, warning that panic buying could recreate gaps. Diabetes advocacy groups published a hotline list for pharmacies participating in a redistribution program sponsored by three manufacturers.
For the health desk, the episode shows how Korea’s strong generics sector still depends on imported devices for precision dosing—and how logistics shocks can look like manufacturing crises at the counter.
Manufacturer statements
Multinational suppliers said port congestion in Busan eased after typhoon season, allowing refrigerated containers to clear customs within 48 hours again. Domestic fill-finish partners credited new automated inspection lines for cutting release times by a day.
Pediatricians asked the association to maintain a public dashboard of pen availability by dose increment through December, arguing transparency prevents unnecessary hospital visits. The association said it is evaluating the request.
Insurance angle
National Health Insurance Service officials confirmed copay rules for insulin remain unchanged, rejecting social media rumors of emergency price hikes. Patients switching to vials temporarily will not lose reimbursement if prescribers document medical necessity.
Rural clinics
County health centers outside major cities said vial supplies are adequate but cold-storage space is tight when flu vaccines share the same refrigerators. The association is coordinating weekend deliveries to islands where pen shipments arrive by ferry.
Endocrinology societies reminded patients to rotate injection sites and store pens at recommended temperatures after ferry delays left some shipments sitting on docks for extra hours.
Wholesalers said they will keep an emergency hotline open through November for pharmacies that need overnight pen transfers from central warehouses in Icheon.
Looking ahead
Manufacturers expect normal stock levels by mid-November if no new port disruptions occur, but pharmacists asked patients to call ahead before traveling to rural areas.